{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:29:00Z","timestamp":1783196940613,"version":"3.54.6"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI139172"],"award-info":[{"award-number":["R01 AI139172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI127406"],"award-info":[{"award-number":["R01 AI127406"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 144694"],"award-info":[{"award-number":["R01 144694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A successful Staphylococcus aureus vaccine remains elusive, and one controversy in the field is whether humans generate a protective adaptive immune response to infection. We developed a bacterial challenge murine assay that directly assesses the protective capacity of adoptively transferred human serum samples. We first validated the model by showing that postpneumococcal vaccine serum samples from humans induced effective clearance of Streptococcus pneumoniae in mice. We then found that human serum samples adoptively transferred from children with invasive S. aureus infections exhibited protection from disease in a murine model, with some samples conferring near complete protection. These findings demonstrate that human serum samples are capable of conferring a protective adaptive response generated by humans during invasive staphylococcal disease, allowing for the study of protective factors in a murine model. Identification of the protective factors present in the most efficacious serum samples would be of high interest as potential staphylococcal vaccine candidates or passive therapeutics.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa482","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T19:11:23Z","timestamp":1596222683000},"page":"1222-1231","source":"Crossref","is-referenced-by-count":9,"title":["Adoptive Transfer of Serum Samples From Children With Invasive Staphylococcal Infection and Protection Against <i>Staphylococcus aureus<\/i> Sepsis"],"prefix":"10.1093","volume":"223","author":[{"given":"Chih-Ming","family":"Tsai","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Soper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K","family":"Fallon","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlin R","family":"Michell","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-9215","authenticated-orcid":false,"given":"Galit","family":"Alter","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"2021040816390958800_CIT0001","doi-asserted-by":"crossref","first-page":"e20153099","DOI":"10.1542\/peds.2015-3099","article-title":"Changing susceptibility of Staphylococcus aureus in a US pediatric population","volume":"137","author":"Sutter","year":"2016","journal-title":"Pediatrics"},{"key":"2021040816390958800_CIT0002","doi-asserted-by":"crossref","first-page":"e20160101","DOI":"10.1542\/peds.2016-0101","article-title":"Staphylococcus aureus infections in children: the implications of changing trends","volume":"137","author":"Kaplan","year":"2016","journal-title":"Pediatrics"},{"key":"2021040816390958800_CIT0003","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"2021040816390958800_CIT0004","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2013.04.002","article-title":"Vaccine review: \u201cStaphyloccocus aureus vaccines: problems and prospects.\u201d","volume":"31","author":"Jansen","year":"2013","journal-title":"Vaccine"},{"key":"2021040816390958800_CIT0005","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4161\/hv.6.12.12917","article-title":"Searching for the holy grail of a staphylococcal vaccine","volume":"6","author":"Thomsen","year":"2010","journal-title":"Hum Vaccin"},{"key":"2021040816390958800_CIT0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/1469-0691.12570","article-title":"Where does a Staphylococcus aureus vaccine stand?","volume":"20(suppl 5)","author":"Fowler","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2021040816390958800_CIT0007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcimb.2012.00016","article-title":"Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials","volume":"2","author":"Bagnoli","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2021040816390958800_CIT0008","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro3521","article-title":"Staphylococcal manipulation of host immune responses","volume":"13","author":"Thammavongsa","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"2021040816390958800_CIT0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrmicro3161","article-title":"Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus","volume":"12","author":"Foster","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2021040816390958800_CIT0010","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/AAC.01213-16","article-title":"Improved protection in a rabbit model of community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia upon neutralization of leukocidins in addition to alpha-hemolysin","volume":"60","author":"Diep","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021040816390958800_CIT0011","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1073\/pnas.1305121110","article-title":"Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1","volume":"110","author":"DuMont","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021040816390958800_CIT0012","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2180-10-173","article-title":"Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions","volume":"10","author":"McCarthy","year":"2010","journal-title":"BMC Microbiol"},{"key":"2021040816390958800_CIT0013","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/IAI.01558-13","article-title":"Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB","volume":"82","author":"Thomsen","year":"2014","journal-title":"Infect Immun"},{"key":"2021040816390958800_CIT0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fimmu.2014.00467","article-title":"Neutrophil-mediated phagocytosis of Staphylococcus aureus","volume":"5","author":"van Kessel","year":"2014","journal-title":"Front Immunol"},{"key":"2021040816390958800_CIT0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1159\/000360478","article-title":"Phagocytosis and killing of Staphylococcus aureus by human neutrophils","volume":"6","author":"Lu","year":"2014","journal-title":"J Innate Immun"},{"key":"2021040816390958800_CIT0016","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/infdis\/jix071","article-title":"Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB isolated following invasive human infection reveal diverse binding and modes of action","volume":"215","author":"Thomsen","year":"2017","journal-title":"J Infect Dis"},{"key":"2021040816390958800_CIT0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcf.2015.12.023","article-title":"Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis","volume":"15","author":"Chadha","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2021040816390958800_CIT0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jpids\/piy017","article-title":"Serologic detection of antibodies targeting the leukocidin LukAB strongly predicts Staphylococcus aureus in children with invasive infection","volume":"8","author":"Wood","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2021040816390958800_CIT0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mbo3.55","article-title":"Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability","volume":"2","author":"Kolar","year":"2013","journal-title":"Microbiologyopen"},{"key":"2021040816390958800_CIT0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fcimb.2017.00166","article-title":"Staphylococcus aureus manipulates innate immunity through own and host-expressed proteases","volume":"7","author":"Pietrocola","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2021040816390958800_CIT0021","doi-asserted-by":"crossref","first-page":"428","DOI":"10.15252\/embr.201540994","article-title":"Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis","volume":"17","author":"Reyes-Robles","year":"2016","journal-title":"EMBO Rep"},{"key":"2021040816390958800_CIT0022","article-title":"Regulation of Staphylococcus aureus virulence","volume":"6:1\u201334","author":"Jenul","year":"2018","journal-title":"Microbiol Spectr"},{"key":"2021040816390958800_CIT0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2012.09.007","article-title":"High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples","volume":"386","author":"Brown","year":"2012","journal-title":"J Immunol Methods"},{"key":"2021040816390958800_CIT0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"Ackerman","year":"2011","journal-title":"J Immunol Methods"},{"key":"2021040816390958800_CIT0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2019.05.006","article-title":"A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis","volume":"471","author":"Karsten","year":"2019","journal-title":"J Immunol Methods"},{"key":"2021040816390958800_CIT0026","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies. An update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2021040816390958800_CIT0027","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/CVI.00506-09","article-title":"Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population","volume":"17","author":"Colque-Navarro","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2021040816390958800_CIT0028","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/infdis\/jis462","article-title":"Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections","volume":"206","author":"Adhikari","year":"2012","journal-title":"J Infect Dis"},{"key":"2021040816390958800_CIT0029","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/501471","article-title":"Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage","volume":"193","author":"Clarke","year":"2006","journal-title":"J Infect Dis"},{"key":"2021040816390958800_CIT0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2017.10.006","article-title":"Staphylococcus aureus epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses","volume":"22","author":"Liu","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2021040816390958800_CIT0031","doi-asserted-by":"crossref","first-page":"E11111","DOI":"10.1073\/pnas.1808353115","article-title":"Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory","volume":"115","author":"Chan","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021040816390958800_CIT0032","doi-asserted-by":"crossref","first-page":"e1005292","DOI":"10.1371\/journal.ppat.1005292","article-title":"Increased susceptibility of humanized NSG mice to Panton-Valentine leukocidin and Staphylococcus aureus skin infection","volume":"11","author":"Tseng","year":"2015","journal-title":"PLoS Pathog"},{"key":"2021040816390958800_CIT0033","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/infdis\/jiy635","article-title":"Human mAbs to Staphylococcus aureus IsdA provide protection through both heme-blocking and Fc-mediated mechanisms","volume":"219","author":"Bennett","year":"2019","journal-title":"J Infect Dis"},{"key":"2021040816390958800_CIT0034","doi-asserted-by":"crossref","first-page":"e02473-19","DOI":"10.1128\/mBio.02473-19","article-title":"Human VH1-69 gene-encoded human monoclonal antibodies against Staphylococcus aureus IsdB use at least three distinct modes of binding to inhibit bacterial growth and pathogenesis","volume":"10","author":"Bennett","year":"2019","journal-title":"mBio"},{"key":"2021040816390958800_CIT0035","doi-asserted-by":"crossref","first-page":"e00528-16","DOI":"10.1128\/mBio.00528-16","article-title":"Targeting alpha toxin and ClfA with a multimechanistic monoclonal-antibody-based approach for prophylaxis of serious Staphylococcus aureus disease","volume":"7","author":"Tkaczyk","year":"2016","journal-title":"mBio"},{"key":"2021040816390958800_CIT0036","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QCO.0000000000000156","article-title":"Host factors that contribute to recurrent staphylococcal skin infection","volume":"28","author":"Montgomery","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"2021040816390958800_CIT0037","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/00365548409073971","article-title":"Recurrent staphylococcal furunculosis: antibody response against Staphylococcus aureus","volume":"16","author":"Espersen","year":"1984","journal-title":"Scand J Infect Dis"},{"key":"2021040816390958800_CIT0038","first-page":"259","article-title":"Staphylococcal opsonization and anti-Staphylococcus aureus IgG subclass antibodies in patients with severe or recurrent S. aureus infections","volume":"2","author":"Monteil","year":"1990","journal-title":"FEMS Microbiol Immunol"},{"key":"2021040816390958800_CIT0039","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10096-010-0888-0","article-title":"Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia","volume":"29","author":"Verkaik","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021040816390958800_CIT0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/CDLI.12.3.387-398.2005","article-title":"Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients","volume":"12","author":"Dryla","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2021040816390958800_CIT0041","doi-asserted-by":"crossref","first-page":"e18617","DOI":"10.1371\/journal.pone.0018617","article-title":"Global changes in Staphylococcus aureus gene expression in human blood","volume":"6","author":"Malachowa","year":"2011","journal-title":"PLoS One"},{"key":"2021040816390958800_CIT0042","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/AEM.05316-11","article-title":"Expression of virulence factors by Staphylococcus aureus grown in serum","volume":"77","author":"Oogai","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"2021040816390958800_CIT0043","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/cid\/cit123","article-title":"A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection","volume":"56","author":"Fritz","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021040816390958800_CIT0044","doi-asserted-by":"crossref","first-page":"e1000715","DOI":"10.1371\/journal.ppat.1000715","article-title":"Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils","volume":"6","author":"L\u00f6ffler","year":"2010","journal-title":"PLoS Pathog"},{"key":"2021040816390958800_CIT0045","doi-asserted-by":"crossref","first-page":"e02369-14","DOI":"10.1128\/mBio.02369-14","article-title":"Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs","volume":"6","author":"Kim","year":"2015","journal-title":"mBio"},{"key":"2021040816390958800_CIT0046","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1084\/jem.20141404","article-title":"Staphylococcus aureus infection induces protein A-mediated immune evasion in humans","volume":"211","author":"Pauli","year":"2014","journal-title":"J Exp Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa482\/33803140\/jiaa482.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/7\/1222\/36993004\/jiaa482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/7\/1222\/36993004\/jiaa482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:18:42Z","timestamp":1617927522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/7\/1222\/5912811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,8,6]]},"published-print":{"date-parts":[[2021,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa482","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,8,6]]}}}